These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19703373)

  • 21. [Effect of quateron on cardiac catecholamines].
    Esaian NA; Kazarova EK
    Zh Eksp Klin Med; 1968; 8(3):3-10. PubMed ID: 16541583
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular properties and anti-muscarinic activity in some series of quaternary ammonium sslts.
    Pratesi P; Villa L; Ferri V; Grana E; Sossi D
    Farmaco Sci; 1969 Mar; 24(3):313-28. PubMed ID: 5769166
    [No Abstract]   [Full Text] [Related]  

  • 23. Nocturnal polyuria and nocturnal arginine vasopressin (AVP): a key factor in the pathophysiology of monosymptomatic nocturnal enuresis.
    AbdelFatah D; Shaker H; Ismail M; Ezzat M
    Neurourol Urodyn; 2009; 28(6):506-9. PubMed ID: 19260089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion of the mouse Fmo1 gene results in enhanced pharmacological behavioural responses to imipramine.
    Hernandez D; Janmohamed A; Chandan P; Omar BA; Phillips IR; Shephard EA
    Pharmacogenet Genomics; 2009 Apr; 19(4):289-99. PubMed ID: 19262426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy of an enuresis alarm in monosymptomatic nocturnal enuresis.
    Ozgür BC; Ozgür S; Doğan V; Orün UA
    Singapore Med J; 2009 Sep; 50(9):879-80. PubMed ID: 19787175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1-Malonyl-1,4-dihydropyridine as a novel carrier for specific delivery of drugs to the brain.
    Hassan HA; Abdel-Aziz M; Abuo-Rahma Gel-D; Farag HH
    Bioorg Med Chem; 2009 Feb; 17(4):1681-92. PubMed ID: 19147368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of imipramine-imipraminium in mice. To elucidate central or peripheral origin of effects of imipramine.
    Frances H; Simon P
    Neuropharmacology; 1985 Jul; 24(7):659-63. PubMed ID: 4022276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soft drugs. 21. Design and evaluation of soft analogs of propantheline.
    Brouillette G; Kawamura M; Kumar GN; Bodor N
    J Pharm Sci; 1996 Jun; 85(6):619-23. PubMed ID: 8773959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, radiosynthesis and biological evaluation of 1,4-dihydroquinoline derivatives as new carriers for specific brain delivery.
    Foucout L; Gourand F; Dhilly M; Bohn P; Dupas G; Costentin J; Abbas A; Marsais F; Barré L; Levacher V
    Org Biomol Chem; 2009 Sep; 7(18):3666-73. PubMed ID: 19707670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structured desmopressin withdrawal improves response and treatment outcome for monosymptomatic enuretic children.
    Marschall-Kehrel D; Harms TW;
    J Urol; 2009 Oct; 182(4 Suppl):2022-6. PubMed ID: 19695616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [AMBULATORY TREATMENT OF NOCTURNAL ENURESIS WITH IMIPRAMINE].
    KULE J
    Cesk Psychiatr; 1963 Jun; 59():182-3. PubMed ID: 14081809
    [No Abstract]   [Full Text] [Related]  

  • 32. [Synthesis and pharmacological study of new amidines and quaternary ammonium salts derivatives of pyrrolidine (author's transl)].
    Kolocouris N; Costakis E; Romond C; Dubreuil L; Devos J; Cazin M; Brunet C; Cazin JC
    Ann Pharm Fr; 1981 Jul; 39(3):201-13. PubMed ID: 7294649
    [No Abstract]   [Full Text] [Related]  

  • 33. A controlled trial of imipramine in the treatment of nocturnal enuresis in mentally subnormal patients.
    FISHER GW; MURRAY F; WALLEY MR; KILOH LG
    Am J Ment Defic; 1963 Jan; 67():536-8. PubMed ID: 13945278
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapeutic approach of enuresis based on the differentiation of the enuretic syndrome and monosymptomatic enuresis].
    García Palacios M; Somoza I; Lema A; Molina ME; Gómez Veiras J; Tellado M; Dargallo T; Pais E; Vela D
    Cir Pediatr; 2009 Apr; 22(2):100-2. PubMed ID: 19715135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and in vitro studies on a potential dopamine prodrug.
    Giannola LI; De Caro V; Giandalia G; Siragusa MG; Lamartina L
    Pharmazie; 2008 Oct; 63(10):704-10. PubMed ID: 18972830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spectrum of central anticholinergic adverse effects associated with oxybutynin: comparison of pediatric and adult cases.
    Gish P; Mosholder AD; Truffa M; Johann-Liang R
    J Pediatr; 2009 Sep; 155(3):432-4. PubMed ID: 19732583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular requirements of the active sites of the cholinergic receptors. XIII - Stereospecific synthesis of 3c-methyl-2t-hydroxy-lr-dimethyl-aminomethylcyclopentane methiodide and its dehydroderivative.
    Giannella M; Leonelli M; Pigini M
    Farmaco Sci; 1980 Apr; 35(4):263-8. PubMed ID: 6450061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quaternary ammonium salt derivatives of allylphenols with peripheral analgesic effect.
    de Oliveira AB; Silva TH; Ferreira SH; Lorenzetti BB
    Mem Inst Oswaldo Cruz; 1991; 86 Suppl 2():133-6. PubMed ID: 1841986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and oxidation-induced DNA cross-linking capabilities of bis(catechol) quaternary ammonium derivatives.
    Song Z; Weng X; Weng L; Huang J; Wang X; Bai M; Zhou Y; Yang G; Zhou X
    Chemistry; 2008; 14(19):5751-4. PubMed ID: 18491338
    [No Abstract]   [Full Text] [Related]  

  • 40. IMIPRAMINE (TOFRANIL) IN THE CONTROL OF ENURESIS.
    EPSTEIN SJ; GUILFOYLE FM
    Am J Dis Child; 1965 May; 109():412-5. PubMed ID: 14280136
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.